Evidence map›Paper›PMID 32490661›Full record

ArticleACS applied materials & interfaces2020

Conjugating Micropatches to Living Cells Through Membrane Intercalation.

Yu Miao, Hailing Liu, Wenhao Cheng, Yang Liu, Sundol Kim, Xuegang Yuan, Aubrey Kusi-Appiah, Steven Lenhert, Teng Ma, Yi Ren and 2 more

Open access · greenAbstract read
In one paragraph

Article in ACS applied materials & interfaces, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Yu MiaoDepartment of Chemical and Biomedical Engineering, Florida A&M University-Florida State University College of Engineering, Tallahassee, Florida 32310, United States.
Hailing LiuDepartment of Chemical and Biomedical Engineering, Florida A&M University-Florida State University College of Engineering, Tallahassee, Florida 32310, United States.
Wenhao ChengDepartment of Chemical and Biomedical Engineering, Florida A&M University-Florida State University College of Engineering, Tallahassee, Florida 32310, United States.
Yang LiuGuizhou Medical University, Guiyang, Guizhou Province 550025, China.
Sundol KimDepartment of Chemical and Biomedical Engineering, Florida A&M University-Florida State University College of Engineering, Tallahassee, Florida 32310, United States.
Xuegang YuanDepartment of Chemical and Biomedical Engineering, Florida A&M University-Florida State University College of Engineering, Tallahassee, Florida 32310, United States.
Aubrey Kusi-AppiahDepartment of Biological Science, Florida State University, Tallahassee, Florida 32306, United States.
Steven LenhertDepartment of Biological Science, Florida State University, Tallahassee, Florida 32306, United States.
Teng MaDepartment of Chemical and Biomedical Engineering, Florida A&M University-Florida State University College of Engineering, Tallahassee, Florida 32310, United States.
Yi RenCollege of Medicine, Florida State University, Tallahassee, Florida 32306, United States.
Hoyong ChungDepartment of Chemical and Biomedical Engineering, Florida A&M University-Florida State University College of Engineering, Tallahassee, Florida 32310, United States.
Jingjiao GuanDepartment of Chemical and Biomedical Engineering, Florida A&M University-Florida State University College of Engineering, Tallahassee, Florida 32310, United States.ORCID http://orcid.org/0000-0002-8389-4067
Florida A&M University - Florida State University College of Engineering · USFlorida State University · US

Funding

Microdevice-Armed Macrophage For Treating CancerR03CA202334 · NCI · FLORIDA STATE UNIVERSITY · PI GUAN, JINGJIAO, REN, YI · 2017 to 2018
$141k
NCI NIH HHS R03 CA202334
6 · The paper itself

Abstract

Existing clinical cell therapies, which rely on the use of biological functionalities of living cells, can be further enhanced by conjugating functional particles to the cells to form cell-particle complexes. Disk-shaped microparticles produced by the top-down microfabrication approach possess unique advantages for this application. However, none of the current mechanisms for conjugating the microfabricated microparticles to the cells are principally applicable to all types of cells with therapeutic potentials. On the other hand, membrane intercalation is a well-established mechanism for attaching fluorescent molecules to living cells or for immobilizing cells on a solid surface. This paper reports a study on conjugating disk-shaped microparticles, referred to as micropatches, to living cells through membrane intercalation for the first time. The procedure for producing the cell-micropatch complexes features an unprecedented integration of microcontact printing of micropatches, end-grafting of linear molecules of octadecyl chain and poly(ethylene glycol) to the printed micropatches, and use of gelatin as a temperature-sensitive sacrificial layer to allow the formation and subsequent release of the cell-micropatch complexes. Complexes composed of mouse neuroblastoma cells were found to be stable in vitro, and the micropatch-bound cells were viable, proliferative, and differentiable. Moreover, complexes composed of four other types of cells were produced. The membrane-intercalation mechanism and the corresponding fabrication technique developed in this study are potentially applicable to a wide range of therapeutic cells and thus promise to be useful for developing new cell therapies enhanced by the disk-shaped microparticles.

Indexed as

Cell- and Tissue-Based TherapyCell-Derived MicroparticlesCell DifferentiationCell ProliferationHumansMesenchymal Stem CellsMicrotechnologyParticle SizePolyethylene GlycolsTemperaturePolyethylene Glycolscell therapydrug deliveryhuman mesenchymal stem cellsmembrane intercalationmicrofabricationmicroparticlePEG

Identifiers

PMID32490661
PMCPMC8640532
OpenAlexW3032478814

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.